Torpenz Tablet
Product Images NDC 0245-0822

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Torpenz (NDC 0245-0822). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Torpenz 01)

Chemical structure of Everolimus, the active ingredient in TORPENZ tablets by Upsher-Smith Laboratories, LLC. This molecular diagram illustrates the arrangement of atoms and bonds characteristic of Everolimus.*

FDA Label Image

Figure 1 (Torpenz 02)

A Kaplan-Meier survival curve chart showing progression-free survival probability (%) over time in months. It compares Everolimus 10 mg plus exemestane versus placebo plus exemestane treatment groups, illustrating higher survival probability for Everolimus. The chart includes censoring times, hazard ratio, confidence intervals, median survival times, and a logrank p value.*

FDA Label Image

Principal Display Panel (2.5 mg Tablet Bottle Label)

Label for TORPENZ (everolimus) Tablets 2.5 mg by Upsher-Smith Laboratories, LLC. The label indicates 30 tablets in the package, includes storage instructions, and states the product is prescription-only. The NDC code 0245-0822-30 is shown with branding and dosage strength prominently displayed.*

FDA Label Image

Principal Display Panel (5 mg Tablet Bottle Label)

Label for TORPENZ (everolimus) Tablets 5 mg by Upsher-Smith Laboratories, LLC. The label indicates a package of 30 tablets for oral use, with each tablet containing 5 mg of everolimus. It includes dosage instructions to see the package insert, storage conditions, child-resistance notice, and manufacturing details including barcode and trademark information.*

FDA Label Image

Principal Display Panel (7.5 mg Tablet Bottle Label)

Label for TORPENZ (everolimus) 7.5 mg tablets, an oral medication by Upsher-Smith Laboratories, LLC. The label states the quantity as 30 tablets, includes dosage form and strength, and features storage instructions along with a barcode and serialization area. It also notes the product is child-resistant and for prescription use only.*

FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

Label for TORPENZ (everolimus) Tablets 10 mg, oral dosage form in a 30-tablet package. Manufactured for Upsher-Smith Laboratories, LLC. The label includes storage instructions, Rx only designation, barcode, and batch serialization area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.